Human Reproduction, Vol. 15, No. 7, 1440-1445,
July 2000
© 2000 European Society of Human Reproduction and Embryology
Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH
University Department of Obstetrics & Gynaecology, Royal Infirmary, Glasgow
There has been much debate about the role of luteinizing hormone (LH) during follicle stimulating hormone (FSH)-treated ovarian stimulation for assisted reproduction, where the endogenous LH is suppressed using a gonadotrophin-releasing hormone analogue. The requirement for LH in oestradiol biosynthesis is established, but other effects of `insufficiency' are less clear, and little attention has been paid to the specific origin of the FSH used. The aim of this study was to examine the roles of profoundly suppressed circulating LH concentrations in cycles of ovarian stimulation for IVF, which were affected in two large separate cohorts of patients undergoing assisted reproduction. They were stimulated by either purified urinary FSH (MHP) or recombinant human FSH (rFSH). Within each dataset, outcomes were examined with respect to the circulating concentrations of LH in the mid-follicular phase, as plasma samples were stored prospectively, and assayed retrospectively. Patients with profoundly suppressed LH showed much reduced oestradiol concentrations at mid-follicular phase and at human chorionic gonadotrophin administration in cycles treated with either MHP or rFSH. However, gross ovarian response, as became evident by FSH dose demands, duration of stimulation, and also oocyte and embryo yields and embryo cryopreservation were influenced only in cycles treated with MHP. Furthermore, no effect upon pregnancy survival was observed. Thus, it is concluded that there is a demand for additional exogenous LH treatment only in cycles treated with purified urinary FSH where the LH is profoundly suppressed.
Key words: follicle stimulating hormone/follicular growth/gonadotrophins/luteinising hormone/ovarian stimulation
1 To whom correspondence should be addressed at: University Department of Obstetrics & Gynaecology, Level 3, QEII Building, Royal Infirmary, Glasgow G31 2ER, UK. E-mail: gqta{at}udcf.gla.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Fleming Progesterone elevation on the day of hCG: methodological issues Hum. Reprod. Update, June 2, 2008; (2008) dmn019v1. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Smitz, A.N. Andersen, P. Devroey, J.-C. Arce, and for the MERIT Group Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients Hum. Reprod., March 1, 2007; 22(3): 676 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.M. Kolibianakis, J. Collins, B. Tarlatzis, E. Papanikolaou, and P. Devroey Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review Hum. Reprod. Update, January 1, 2006; 12(1): 3 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bjercke, P. Fedorcsak, T. Abyholm, R. Storeng, G. Ertzeid, N. Oldereid, A. Omland, and T. Tanbo IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression Hum. Reprod., September 1, 2005; 20(9): 2441 - 2447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Griesinger, A. Schultze-Mosgau, K. Dafopoulos, A. Schroeder, A. Schroer, S. von Otte, D. Hornung, K. Diedrich, and R. Felberbaum Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol Hum. Reprod., May 1, 2005; 20(5): 1200 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.M. Kolibianakis, K. Zikopoulos, J. Schiettecatte, J. Smitz, H. Tournaye, M. Camus, A.C. Van Steirteghem, and P. Devroey Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF Hum. Reprod., November 1, 2004; 19(11): 2490 - 2496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Miro, S. W. Parker, L. J. Aspinall, J. Coley, P. W. Perry, and J. E. Ellis Relationship between Follicle-Stimulating Hormone Levels at the Beginning of the Human Menstrual Cycle, Length of the Follicular Phase and Excreted Estrogens: The FREEDOM Study J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3270 - 3275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Penarrubia, F. Fabregues, M. Creus, D. Manau, R. Casamitjana, M. Guimera, F. Carmona, J. A. Vanrell, and J. Balasch LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH Hum. Reprod., December 1, 2003; 18(12): 2689 - 2697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Al-Inany, M. Aboulghar, R. Mansour, and G. Serour Meta-analysis of recombinant versus urinary-derived FSH: an update Hum. Reprod., February 1, 2003; 18(2): 305 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tesarik and C. Mendoza Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence Hum. Reprod., December 1, 2002; 17(12): 3129 - 3137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Balasch The potential value of mid-follicular phase LH Hum. Reprod., February 1, 2002; 17(2): 518 - 520. [Full Text] [PDF]
|
|
|
|
|
|
M. Filicori The potential value of mid-follicular phase LH Hum. Reprod., February 1, 2002; 17(2): 517 - 520. [Full Text] [PDF]
|
|
|
|
|
|
G. De Placido, A. Mollo, C. Alviggi, I. Strina, M. T. Varricchio, A. Ranieri, N. Colacurci, A. Tolino, and M. Wilding Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH Hum. Reprod., September 1, 2001; 16(9): 1875 - 1879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Balasch, E. Vidal, J. Penarrubia, R. Casamitjana, F. Carmona, M. Creus, F. Fabregues, and J. A. Vanrell Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH Hum. Reprod., August 1, 2001; 16(8): 1636 - 1643. [Abstract] [Full Text] [PDF]
|
|